MedTrace Logo

Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes

NCT00537303 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2017-03-10

Study results available
· View outcomes & findings →

Summary

This trial is conducted in Europe, Africa and the United States of America (USA).

The aim of this trial is to compare the safety and efficacy of two different insulin treatments, the "basic" and the "advanced" treatment in type 2 diabetes.

Conditions

Interventions

DRUG

insulin detemir

Treat-to-target dose titration scheme (individually adjusted dose) for a once daily injection s.c. (under the skin)

DRUG

insulin aspart

Administered 1 - 3 times daily, at largest prandial increment, injection s.c. (under the skin)

DRUG

insulin aspart

Administered 1 - 3 times daily, at largest meals, injection s.c. (under the skin)

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States
  • Denmark
  • Finland
  • France
  • Netherlands
  • Norway
  • Russia
  • Serbia and Montenegro
  • South Africa
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00537303 on ClinicalTrials.gov